Stockscreener 앱 받기
210.64
0.60%
1.25
전일 마감가:
$209.39
열려 있는:
$209.39
하루 거래량:
451.61K
Relative Volume:
0.52
시가총액:
$15.13B
수익:
$2.90B
순이익/손실:
$467.20M
주가수익비율:
33.07
EPS:
6.37
순현금흐름:
$306.90M
1주 성능:
-0.18%
1개월 성능:
-0.31%
6개월 성능:
-34.56%
1년 성능:
-35.92%
1일 변동 폭
$206.19
$212.34
1주일 범위
$206.10
$213.84
52주 변동 폭
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
210.64 | 15.16B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
551.85 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
170.66 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.43 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
247.05 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.09 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
West Pharmaceutical Services: Mixed Results And A Pricey Stock Makes This A Pass (WST) - Seeking Alpha
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025 - ACCESS Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - Morningstar
Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire
If you are a Long-Term Shareholder of DoubleVerify - GlobeNewswire
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your RightsContact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - PR Newswire
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) -Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued? - Yahoo Finance
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. InvestorsLead Plaintiff Deadline July 7, 2025 - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to ... - Enidnews.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.July 7, 2025 Deadline - ACCESS Newswire
Class Action Filed Against West Pharmaceutical Services, - GlobeNewswire
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - PR Newswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST)July 7, 2025 Deadline to ... - Bluefield Daily Telegraph
Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025 - ACCESS Newswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc. (NYSE: WS - Morningstar
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - marketscreener.com
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
3 Dividend Aristocrats Wall Street Says Can Soar 48% in 2025 - 24/7 Wall St.
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about pending Class ActionWST - PR Newswire
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Notifies Shareholders of West - GlobeNewswire
The Gross Law Firm Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class ... - Bluefield Daily Telegraph
West Pharmaceutical Services: Still Potential Downside Ahead (NYSE:WST) - Seeking Alpha
Contact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST) - marketscreener.com
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
WST Investors Have the Opportunity to Lead the West - GlobeNewswire
WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit ... - Bluefield Daily Telegraph
Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) – Join by July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
West Pharmaceutical Stock: Analyst Estimates & Ratings - MSN
West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your RightsWST - Morningstar
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors ... - Eagle-Tribune
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionWST - ACCESS Newswire
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action - ACCESS Newswire
Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.83%
0.13%
자본화:
|
볼륨(24시간):